1. Wide of President walking to Rose Garden podium
2. Cutaway, profile of President speaking
3. SOUNDBITE: (English) George W. Bush, US President:
"We know that the terrorists seek an even deadlier technology. And if they acquire chemical, biological or nuclear weapons, we have no doubt they will use them to cause even greater harm. The bill I am about to sign is an important element in our response to that threat."
4. Cutaway of audience
5. SOUNDBITE: (English) George W. Bush, US President :
"Project BioShield will transform our ability to defend the nation in three essential ways. First, Project BioShield authorizes $5.6 billion over 10 years for the government to purchase and stockpile vaccines and drugs to fight anthrax, smallpox and other potential agents of bioterror."
6. Cutaway, medium of audience members
7. Mid-view, President Bush signing the bill, shakes hands
President George W. Bush on Wednesday signed legislation to develop and stockpile vaccines and other antidotes to chemical and germ
attacks, saying the measure will "rally the great promise of American science and innovation to confront the greatest danger of our time."
The legislation, called Project BioShield, provides the drug industry with incentives to research and develop bioterrorism countermeasures. It speeds up the approval process of antidotes and, in an emergency, allows the government to distribute certain treatments before the Food and Drug Administration has approved them.
"We know that the terrorists seek an even deadly technology, and if they acquire chemical, biological or nuclear weapons we have no doubt they will
use them to cause even greater harm," Bush said in the Rose Garden.
He said the legislation sends a message about America's direction in the war on terror - that the United States refuses to stand idle "when modern technology might be turned against us."
U.S. officials are hoping that Project BioShield will yield enough new-generation anthrax vaccine to dose 25 million people.
Federal health officials also hope that the $5.6 billion program will provide antidotes for botulism and anthrax, a safer smallpox vaccine and a long-awaited children's version of an anti-radiation pill.